Multiple melanocortin receptors are expressed in bone cells

Bone

Volumn 36, Issue 5, 2005, Pages 820-831

  Zhong, Qing ^a,b   Sridhar, Supriya ^a   Ruan, Ling ^a   Ding, Ke Hong ^a,b   Xie, Ding ^a   Insogna, Karl ^d   Kang, Baolin ^a   Xu, Jianrui ^a   Bollag, Roni J ^a   Isales, Carlos M ^a,b,c  

^a Institute of Molecular Medicine and Genetics   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ACTH; Alpha MSH; Endorphin; POMC; Proliferation

Indexed keywords

MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 5 RECEPTOR; MELANOCORTIN RECEPTOR; PROOPIOMELANOCORTIN;

ARTICLE; BINDING AFFINITY; BONE CELL; CELL PROLIFERATION; CELL SUBPOPULATION; GENE EXPRESSION; HORMONE RELEASE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCLAST; PROTEIN EXPRESSION;

EID: 20944434906     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.01.020     Document Type: Article

References (42)

1. Z.A. Abdel-Malek Melanocortin receptors: their functions and regulation by physiological agonists and antagonists Cell. Mol. Life Sci. 58 2001 434 441
2. S. Adachi, T. Nakano, H. Vliagoftis, and D.D. Metcalfe Receptor-mediated modulation of murine mast cell function by alpha-melanocyte stimulating hormone J. Immunol. 163 1999 3363 3368
3. T. Akatsu, T. Tamura, N. Takahashi, N. Udagawa, S. Tanaka, and T. Sasaki Preparation and characterization of a mouse osteoclast-like multinucleated cell population J. Bone Miner. Res. 7 1992 1297 1306
4. P. Aspenberg, L.I. Hansson, and K.G. Thorngren Modification of bone formation rate by growth hormone, melanocyte-stimulating hormone, and cortisone in the normal rat Acta Anat. (Basel) 121 1985 84 88
5. P.Q. Barrett, and C.M. Isales The role of cyclic nucleotides in atrial natriuretic peptide-mediated inhibition of aldosterone secretion Endocrinology 122 1988 799 808
6. J.E. Blalock Proopiomelanocortin and the immune-neuroendocrine connection Ann. N. Y. Acad. Sci. 885 1999 161 172
7. R.J. Bollag, Q. Zhong, K.H. Ding, P. Phillips, L. Zhong, and F. Qin Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects Mol. Cell. Endocrinol. 177 2001 35 41
8. A.A. Butler, and R.D. Cone The melanocortin receptors: lessons from knockout models Neuropeptides 36 2002 77 84
9. A.J. Clark, and A. Weber Adrenocorticotropin insensitivity syndromes Endocr. Rev. 19 1998 828 843
10. J. Cornish, K.E. Callon, K.G. Mountjoy, U. Bava, J.M. Lin, and D.E. Myers Alpha-melanocyte-stimulating hormone is a novel regulator of bone Am. J. Physiol.: Endocrinol. Metab. 284 2003 E1181 E1190
11. D.D. Diascro Jr., R.L. Vogel, T.E. Johnson, K.M. Witherup, S.M. Pitzenberger, and S.J. Rutledge High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells J. Bone Miner. Res. 13 1998 96 106
12. K.H. Ding, Q. Zhong, and C.M. Isales Glucose-dependent insulinotropic peptide stimulates thymidine incorporation in endothelial cells: role of endothelin-1 Am. J. Physiol.: Endocrinol. Metab. 285 2003 E390 E396
13. K.H. Ding, Q. Zhong, J. Xu, and C.M. Isales Glucose-dependent insulinotropic peptide: differential effects on hepatic artery vs. portal vein endothelial cells Am. J. Physiol.: Endocrinol. Metab. 286 2004 E773 E779
14. P. Ducy, M. Amling, S. Takeda, M. Priemel, A.F. Schilling, and F.T. Beil Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass Cell 100 2000 197 207
15. L.M. Dumont, C.S. Wu, C.J. Aschkenasi, J.K. Elmquist, B.B. Lowell, and K.G. Mountjoy Mouse melanocortin-4 receptor gene 5′-flanking region imparts cell specific expression in vitro Mol. Cell. Endocrinol. 184 2001 173 185
16. L.L. Elias, A. Huebner, L.A. Metherell, A. Canas, G.L. Warne, and M.L. Bitti Tall stature in familial glucocorticoid deficiency Clin. Endocrinol. (Oxf.) 53 2000 423 430
17. J.F. Evans, Q.T. Niu, J.A. Canas, C.L. Shen, J.F. Aloia, and J.K. Yeh ACTH enhances chondrogenesis in multipotential progenitor cells and matrix production in chondrocytes Bone 35 2004 96 107
18. M.W. Hamrick, C. Pennington, D. Newton, D. Xie, and C. Isales Leptin deficiency produces contrasting phenotypes in bones of the limb and spine Bone 34 2004 376 383
19. K.L. Insogna, A.F. Stewart, A.M. Vignery, E.C. Weir, P.A. Namnum, and R.E. Baron Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy Endocrinology 114 1984 888 896
20. H.M. Kronenberg Developmental regulation of the growth plate Nature 423 2003 332 336
21. H. Krude, H. Biebermann, W. Luck, R. Horn, G. Brabant, and A. Gruters Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans Nat. Genet. 19 1998 155 157
22. S.K. Lim, S.Z. Li, Y. Rhee, S.S. Chung, Y.J. Jin, and J.I. Yook The effect of alphaMSH analogues on rat bones Yonsei Med. J. 43 2002 500 510
23. P.D. Lyons, and J.E. Blalock The kinetics of ACTH expression in rat leukocyte subpopulations J. Neuroimmunol. 63 1995 103 112
24. P.D. Lyons, and J.E. Blalock Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes J. Neuroimmunol. 78 1997 47 56
25. K.G. Mountjoy, C. Jenny, S. Wu, L.M. Dumont, and J.M. Wild Melanocortin-4 receptor messenger ribonucleic acid expression in rat cardiorespiratory, musculoskeletal, and integumentary systems Endocrinology 144 2003 5488 5496
26. S.A. Mousa, M. Schafer, W.M. Mitchell, A.H. Hassan, and C. Stein Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation Eur. J. Pharmacol. 311 1996 221 231
27. M.T. Nakamura, and T.Y. Nara Structure, function, and dietary regulation of Delta6, Delta5, and Delta9 desaturases Annu. Rev. Nutr. 24 2004 345 376
28. T. Niu, C. Chen, H. Cordell, J. Yang, B. Wang, and Z. Wang A genome-wide scan for loci linked to forearm bone mineral density Hum. Genet. 104 1999 226 233
29. J.J. Orloff, M.B. Ganz, M.H. Nathanson, M.S. Moyer, Y. Kats, and M. Mitnick A midregion parathyroid hormone-related peptide mobilizes cytosolic calcium and stimulates formation of inositol trisphosphate in a squamous carcinoma cell line Endocrinology 137 1996 5376 5385
30. G. Priante, L. Bordin, E. Musacchio, G. Clari, and B. Baggio Fatty acids and cytokine mRNA expression in human osteoblastic cells: a specific effect of arachidonic acid Clin. Sci. (Lond.) 102 2002 403 409
31. D.A. Rees, P.J. Hepburn, A.M. McNicol, K. Francis, B. Jasani, and M.D. Lewis Loss of ACTH expression in cultured human corticotroph macroadenoma cells is consistent with loss of the POMC gene signal sequence Mol. Cell. Endocrinol. 189 2002 51 57
32. M. Schafer, L. Carter, and C. Stein Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue Proc. Natl. Acad. Sci. U. S. A. 91 1994 4219 4223
33. M. Schafer, S.A. Mousa, Q. Zhang, L. Carter, and C. Stein Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia Proc. Natl. Acad. Sci. U. S. A. 93 1996 6096 6100
34. H.B. Schioth The physiological role of melanocortin receptors Vitam. Horm. 63 2001 195 232
35. S. Solomon POMC-derived peptides and their biological action Ann. N. Y. Acad. Sci. 885 1999 22 40
36. A. Stenstrom, L.I. Hansson, and K.G. Thorngren Influence of alpha-MSH and ACTH on cortical bone remodelling in hypophysectomized rats Experientia 35 1979 132 133
37. T. Suda, N. Takahashi, N. Udagawa, E. Jimi, M.T. Gillespie, and T.J. Martin Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families Endocr. Rev. 20 1999 345 357
38. S. Takeda, F. Elefteriou, R. Levasseur, X. Liu, L. Zhao, and K.L. Parker Leptin regulates bone formation via the sympathetic nervous system Cell 111 2002 305 317
39. C. Vaisse, K. Clement, E. Durand, S. Hercberg, B. Guy-Grand, and P. Froguel Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity J. Clin. Invest. 106 2000 253 262
40. E.L. Webster, D.E. Tracey, M.A. Jutila, S.A. Wolfe Jr., and E.B. De Souza Corticotropin-releasing factor receptors in mouse spleen: identification of receptor-bearing cells as resident macrophages Endocrinology 127 1990 440 452
41. L. Yaswen, N. Diehl, M.B. Brennan, and U. Hochgeschwender Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin Nat. Med. 5 1999 1066 1070
42. Q. Zhong, K.H. Ding, A.L. Mulloy, R.J. Bollag, and C.M. Isales Glucose-dependent insulinotropic peptide stimulates proliferation and TGF-beta release from MG-63 cells Peptides 24 2003 611 616